Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
197.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.90 (0.456%)
Market Cap: £1.28b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Holding(s) in Company

12 May 2008 08:40

RNS Number : 1631U
Ashmore Group PLC
12 May 2008
Β 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Β 

Ashmore Group Plc

2.Β Reason for the notificationΒ 

(please place an X inside theΒ appropriateΒ bracket/s):

An acquisition or disposal of voting rights:Β Β Β Yes

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:Β ( Β Β )

An event changing the breakdown of voting rights:Β ( Β  )

Other (please specify) :Β (Β Β  )

3. FullΒ name of person(s) subject toΒ notification obligation:

1. Lone Pine Capital LLC

2. Stephen F Mandel Jr

4. Full name of shareholder(s)Β (if different from 3)Β :

Morgan Stanley & Co

5. Date of transactionΒ (and date on which the threshold is crossed or reachedΒ if different):

28thΒ April 2008

6. Date on which issuer notified:

30thΒ April 2008

7. Threshold(s) that is/are crossed or reached:

3 per cent

Β Β 

8. NotifiedΒ Details:

A: Voting rights attached to shares

Class/type of shares

if possible use ISIN

CODE

Situation previous to the triggering transaction

Number of shares

Number of votingΒ rights

GB00B132NW22

Below 3 per cent

Below 3 per cent

Resulting situation after the triggering transaction

Class/type of shares

if possible use ISIN

CODE

Number of sharesΒ 

Number of voting rights

%Β of voting rights

Direct

Indirect

Direct

Indirect

GB00B132NW22

21,754,134

21,754,134

3.07%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of

Financial

instrument

Expiration

date

Exercise/

Conversion

period/date

No.Β of voting rights

that may be

acquiredΒ (if the

instrument

exercised/

converted)

%Β of voting

rights

Total (A+B)

Number of voting rights

%Β of voting rights

21,754,134

3.07%

9.Β Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicableΒ :

Lone Pine Capital LLC is the investment manager to several funds which indirectly hold shares in the issuer. Stephen.F Mandel Jr. is the Managing Member of Lone PineΒ Capital LLC and in such capacity is able to direct it's operations

Β 

Proxy Voting:

10. Name ofΒ proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

Jeffrey Wechsenblatt

Lone Pine Capital LLC

TwoΒ GreenwichΒ PlazaGreenwichConecticut 06830USA

15. Contact telephone number:

+1 203 618 7826

For notes on how to complete form TR-1 please see the FSA website.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLGUUQWAUPRURP
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.